Eprosartan

CAS 133040-01-4

In Stock

Eprosartan

Cat. No. ANT-EPR-00CAS 133040-01-4In Stock

Technical Data

Cat. No.ANT-EPR-00

CAS133040-01-4

Mol. FormulaC₂₃H₂₄N₂O₄S

Mol. Weight424.51 g/mol

IUPAC4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid

SMILESCCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O

InChIInChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

InChI KeyOROAFUQRIXKEMV-LDADJPATSA-N

PurityNA

Description

Overview

Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed in the United States as Teveten by Abbvie, the spin-off of the pharmaceutical discovery division of Abbott Laboratories; it is marketed as Eprozar by Intas Pharmaceuticals in India, and by Abbott Laboratories elsewhere. The compound came into the Abbott Laboratories cardiovascular pipeline with its acquisition of Kos Pharmaceuticals in 2006, which had licensed it, along with "a range of hypertensive treatments", from the Biovail Corporation

Anant Labs manufacture and furnish high quality Eprosartan impurities for global markets. Our Eprosartan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

(alphaE)-alpha-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid(E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic AcidEprosartan133040-01-4SK&F 108566SK&F-108566SKF-1085662KH13Z0S0YSK-108566CHEBI:4814

Browse APIs A–Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Impurities (1)

Impurity

Eprosartan

Cat. No.: ANT-EPR-00

In StockRFQ

Eprosartan

Eprosartan

Overview

Synonyms

Impurities (1)

Eprosartan

Looking for a specific reference standard?